Dr. Androphy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 University Blvd
Ste 3240
Indianapolis, IN 46202Phone+1 317-944-7744Fax+1 317-944-7051
Education & Training
National Institutes of Health Clinical CenterResidency, Dermatology, 1982 - 1986
UPMC Medical EducationResidency, Dermatology, 1980 - 1982
University of Rochester School of Medicine and DentistryClass of 1979
Certifications & Licensure
IN State Medical License 2010 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow American Academy of Microbiology, 2022
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 738 citationsA Single Nucleotide Difference That Alters Splicing Patterns Distinguishes the SMA Gene SMN1 From the Copy Gene SMN2Umrao R. Monani, Christian L. Lorson, D. William Parsons, Thomas W. Prior, Elliot J. Androphy
Human Molecular Genetics. 1999-07-01 - 121 citationsHow the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophyNatalia N. Singh, Matthew D. Howell, Elliot J. Androphy, Ravindra N. Singh
Gene Therapy. 2017-05-09 - 1181 citationsA single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophyChristian L. Lorson, E. Hahnen, Elliot J. Androphy, Brunhilde Wirth
Proceedings of the National Academy of Sciences of the United States of America. 1999-05-25
Press Mentions
Kovina Therapeutics Receives National Cancer Institute Grant to Advance Human Papillomavirus Cancer TreatmentJune 27th, 2022
Grant Announcement: Cure SMA Awards $150,000 Grant to Timra Gilson, Ph.D., Indiana UniversityMarch 5th, 2020
Grant Support
- Functions Of Papillomavirus E6National Cancer Institute2010–2012
- Small Molecule Inhibitors Of Oncogenic Human PapillomavirusNational Cancer Institute2011
- Control Of Papillomavirus Expression And TransformationNational Cancer Institute2010–2011
- Cooperative LEAD Development Program For Treatment Of Spinal Muscular AtrophyEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
- Testing Compounds That Increase SMN Levels For Efficacy In Mouse Models Of SMANational Institute Of Neurological Disorders And Stroke2010
- Functions Of Papillomavirus E6National Cancer Institute2010
- Small Molecule Inhibitors Of Oncogenic Human PapillomavirusNational Cancer Institute2008–2010
- Testing Compounds That Increase SMN Levels For Efficacy In Mouse Models Of SMANational Institute Of Neurological Disorders And Stroke2009
- Optimization Of Drug-Like Compounds For Treatment Of Spinal Muscular AtrophyEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2009
- Control Of Papillomavirus Expression And TransformationNational Cancer Institute2002–2009
- High Throughput Screen For SMANational Institute Of Mental Health2008
- Functions Of Human Papillomavirus E6National Cancer Institute2004–2008
- High Throughput Screen For Compounds To Treat Papillomavirus Induced CancersNational Cancer Institute2006–2007
- Papillomavirus Inhibitors For Aids-Related MalignanciesNational Cancer Institute2002–2005
- Molecular Pathogenesis Of Spinal Muscular AtrophyNational Institute Of Neurological Disorders And Stroke2001–2004
- Functions Of The Human Papillomavirus E6 OncoproteinNational Cancer Institute2001
- Molecular Pathogenesis Of Spinal Muscular AtrophyNational Institute Of Neurological Disorders And Stroke2000–2001
- Core--Aids Related MalignancyNational Institute Of Allergy And Infectious Diseases1998–2001
- Functions Of The Human Papillomavirus E6 OncoproteinNational Cancer Institute1997–2001
- Control Of Papillomavirus Expression And TransformatioNational Cancer Institute2000
- Control Of Papillomavirus Expression And TransformationNational Cancer Institute1993–1999
- Design Of Human Papillomavirus InhibitorsNational Institute Of Allergy And Infectious Diseases1995–1998
- Papillomavirus E6 ProteinsNational Cancer Institute1994
- Characterization Of Papillomavirus E6 ProteinsNational Cancer Institute1987–1993
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
